Atypical Presentation of Bacteremia in Older Patients Is a Risk Factor for Death.


Journal

The American journal of medicine
ISSN: 1555-7162
Titre abrégé: Am J Med
Pays: United States
ID NLM: 0267200

Informations de publication

Date de publication:
11 2019
Historique:
received: 01 03 2019
revised: 24 04 2019
accepted: 26 04 2019
pubmed: 5 6 2019
medline: 17 3 2020
entrez: 5 6 2019
Statut: ppublish

Résumé

The absence of fever in bacteremia in patients who are older is known to delay diagnosis. Our objective was to determine whether atypical presentation was associated to mortality as a result of bacteremia in this patient cohort as well as possible factors associated with this atypical presentation. We conducted an observational prospective study in 2 French university hospitals in 2016-2017 including patients ages ≥75 years with bacteremia. Atypical presentation was defined as the absence of a temperature ≥38.3°C or <36°C, chills, or hypotension. Mortality and dependence for activities of daily living (ADL) were recorded at 1 week (D7) and 3 months (D90). Among the 151 patients (mean age 85.4±5.8 years) enrolled, atypical presentation prevalence was 21.2%. D7 and D90 mortality rates were 7.9% and 40.0%, respectively. Atypical presentation was independently associated with D7 (odds ratio (OR) 4.46, 95% confidence interval (CI) 1.04-19.24) and D90 mortality (OR 3.76, 95% CI 1.30-10.92) after controlling for other prognostic factors. Patients with diabetes and those infected with Staphylococcus aureus were more likely to have atypical signs of infection. ADL score decreased from 3.6±2.0 before bacteremia to 2.8±2.1 at D90 (P <0.001). Patients who are older with bacteremia have poor vital and functional prognoses in the short and long terms. The absence of typical signs of infection is associated with mortality. Blood culture should be considered for patients who are older, especially with diabetes with acute unexplained clinical manifestations.

Sections du résumé

BACKGROUND
The absence of fever in bacteremia in patients who are older is known to delay diagnosis. Our objective was to determine whether atypical presentation was associated to mortality as a result of bacteremia in this patient cohort as well as possible factors associated with this atypical presentation.
METHODS
We conducted an observational prospective study in 2 French university hospitals in 2016-2017 including patients ages ≥75 years with bacteremia. Atypical presentation was defined as the absence of a temperature ≥38.3°C or <36°C, chills, or hypotension. Mortality and dependence for activities of daily living (ADL) were recorded at 1 week (D7) and 3 months (D90).
RESULTS
Among the 151 patients (mean age 85.4±5.8 years) enrolled, atypical presentation prevalence was 21.2%. D7 and D90 mortality rates were 7.9% and 40.0%, respectively. Atypical presentation was independently associated with D7 (odds ratio (OR) 4.46, 95% confidence interval (CI) 1.04-19.24) and D90 mortality (OR 3.76, 95% CI 1.30-10.92) after controlling for other prognostic factors. Patients with diabetes and those infected with Staphylococcus aureus were more likely to have atypical signs of infection. ADL score decreased from 3.6±2.0 before bacteremia to 2.8±2.1 at D90 (P <0.001).
CONCLUSION
Patients who are older with bacteremia have poor vital and functional prognoses in the short and long terms. The absence of typical signs of infection is associated with mortality. Blood culture should be considered for patients who are older, especially with diabetes with acute unexplained clinical manifestations.

Identifiants

pubmed: 31163127
pii: S0002-9343(19)30450-4
doi: 10.1016/j.amjmed.2019.04.049
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1344-1352.e1

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Caroline Hyernard (C)

CHU Bordeaux, Pôle de Gérontologie Clinique, Bordeaux, France.

Alice Breining (A)

Groupe hospitalier Pitié-Salpêtrière-Charles-Foix, site Charles-Foix, Service de Gériatrie Aigue Polyvalente, Ivry-sur-Seine, France.

Sophie Duc (S)

CHU Bordeaux, Pôle de Gérontologie Clinique, Bordeaux, France.

David Kobeh (D)

CHU Bordeaux, Pôle de Gérontologie Clinique, Bordeaux, France.

Maria Dubos (M)

CHU Bordeaux, Pôle de Gérontologie Clinique, Bordeaux, France.

Renaud Prevel (R)

CHU Bordeaux, Pôle de Gérontologie Clinique, Bordeaux, France.

Charles Cazanave (C)

CHU de Bordeaux, Service des Maladies Infectieuses et Tropicales, Hôpital Pellegrin, Bordeaux, France; Université Bordeaux, Infections Humaines à Mycoplasmes et à Chlamydiae, Bordeaux, France.

Mathieu Lambert (M)

CHU de Bordeaux, Service de Médecine Interne et Post-Urgences, Hôpital Pellegrin, Bordeaux, France.

Fabrice Bonnet (F)

CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Hôpital Saint-André, Bordeaux cedex, France.

Patrick Mercie (P)

CHU de Bordeaux, Service de Médecine Interne et Immunologie Clinique, Hôpital Saint-André, Bordeaux cedex, France.

Anne Contis (A)

CHU de Bordeaux, Service de Médecine Interne et Immunologie Clinique, Hôpital Saint-André, Bordeaux cedex, France.

Piere Duffau (P)

CHU de Bordeaux, Service de Médecine Interne et Immunologie Clinique, Hôpital Saint-André, Bordeaux cedex, France.

Fabrice Camou (F)

CHU Bordeaux, Réanimation Médicale, Groupe Saint-André, Bordeaux cedex, France.

Florent Guerville (F)

CHU Bordeaux, Pôle de Gérontologie Clinique, Bordeaux, France.

Muriel Rainfray (M)

CHU Bordeaux, Pôle de Gérontologie Clinique, Bordeaux, France.

Claire Roubaud-Baudron (C)

CHU Bordeaux, Pôle de Gérontologie Clinique, Bordeaux, France; Université de Bordeaux, INSERM UMR 1053 BaRITOn, Bordeaux, France. Electronic address: claire.roubaud@chu-bordeaux.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH